Crane Capital Associates

Crane Capital Associates appears to be a financial services and investment management firm rather than a life sciences, biotech, pharma, or healthcare operating company. Publicly available references associate the name with venture capital, private equity, hedge fund placement, alternative investment management, and asset management activities, with some sources indicating interest in biotechnology and medical equipment as investment sectors rather than as in-house therapeutic programs. Evidence also suggests that Bear Stearns acquired Crane Capital Associates in February 2007, although legal entities using the name have continued to appear in corporate and regulatory records. Based on the available information, Crane Capital Associates is best characterized as an investment firm with historical exposure to healthcare-related investing, not a drug developer or healthcare products company.